Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $137.2900 (0.23%) ($136.0300 - $137.3900) on Wed. Jan. 12, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.06% (three month average) | RSI | 81 | Latest Price | $137.2900(0.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.2% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(43%) SPLV(33%) XLP(31%) VYM(30%) DIA(29%) | Factors Impacting ABBV price | ABBV will decline at least -0.53% in a week (0% probabilities). VIXM(-19%) UUP(-12%) TBT(-2%) VXX(-0%) EDOC(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.53% (StdDev 1.06%) | Hourly BBV | 1.4 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $136.15(0.84%) | 10 Day Moving Average | $135.88(1.04%) | 20 Day Moving Average | $134.15(2.34%) | To recent high | 0% | To recent low | 27.8% | Market Cap | $242.218b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |